← All news
Markets
AstraZeneca (LSE:AZN) wins EU asthma nod for Trixeo this week: why did the shares still slip?
Highlights AstraZeneca received European Union approval for Trixeo as an asthma treatment. The decision widens the inhaler's use beyond chronic obstructive pulmonary disease. The shares eased in London as the wider pharmaceutical sector tra…
Covered by 1 outlet
All coverage · 1 article